Reviews in Endocrine and Metabolic Disorders

, Volume 5, Issue 3, pp 261–268 | Cite as

Osteoporosis and Diabetes Mellitus

  • Angela M. Inzerillo
  • Solomon Epstein
Article
diabetes bone density fracture osteoporosis osteopenia bone mineral density 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Anonymous. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-650.Google Scholar
  2. 2.
    National Osteoporosis Foundation, Physician's Guide to Prevention and Treatment of Osteoporosis, 2003. 1232 22nd Street NW, Washington, D.C. 20037-1292.Google Scholar
  3. 3.
    Shires R, Teitelbaum SL, Bergfeld MA, Fallon MD, Slatopolsky E, Avioli LV. The effect of streptozotocin-induced chronic diabetes mellitus on bone and mineral homeostasis in the rat. J Lab Clin Med 1981;97:231-240.Google Scholar
  4. 4.
    Goodman WG, Hori MT. Diminished bone formation in experimental diabetes. Relationship to osteoid maturation and mineralization. Diabetes 1984;33:825-831.Google Scholar
  5. 5.
    Thrailkill KM, Liu L, Wahl EC, Liu Z, Bunn RC, Hogue W, Suva LJ, Perrien DS, Fowlkes JL, Aronson J, Lumpkin CK. New bone formation is impaired in a model of type 1 diabetes mellitus. In: 25th Annual Meeting ASBMR, Sept. 19–23, Minneapolis, Minnesota, 2003:SA406.Google Scholar
  6. 6.
    Mishima N, Sahara N, Shirakawa M, Ozawa H. Effect of streptozotocin-induced diabetes mellitus on alveolar bone deposition in the rat. Arch Oral Biol 2002;47:843-849.Google Scholar
  7. 7.
    Bouillon R, Bex M, Van Herck E, Laureys J, Dooms L, Lesaffre E, Ravussin E. Influence of age, sex, and insulin on osteoblast function: Osteoblast dysfunction in diabetes mellitus. J Clin Endocrinol Metab 1995;80:1194-1202.Google Scholar
  8. 8.
    Wu K, Schubeck KE, Frost HM, Villanueva A. Haversian bone formation rates determined by a new method in a mastodon, and in human diabetes mellitus and osteoporosis. Calcif Tissue Res 1970;6:204-219.Google Scholar
  9. 9.
    Glajchen N, Epstein S, Ismail F, Thomas S, Fallon M, Chakrabarti S. Bone mineral metabolism in experimental diabetes mellitus: Osteocalcin as a measure of bone remodeling. Endocrinology 1988;123:290-295.Google Scholar
  10. 10.
    Campos Pastor MM, Lopez-Ibarra PJ, Escobar-Jimenez F, Serrano Pardo MD, Garcia-Cervigon AG. Intensive insulin therapy and bone mineral density in type 1 diabetes mellitus: A prospective study. Osteoporos Int 2000;11:455-459.Google Scholar
  11. 11.
    Bonfanti R, Mora S, Prinster C, Bognetti E, Meschi F, Puzzovio M, Proverbio MC, Chiumello G. Bone modeling indexes at onset and during the first year of follow-Up in insulin-dependent diabetic children. Calcif Tissue Int 1997;60:397-400.Google Scholar
  12. 12.
    Valerio G, del Puente A, Esposito-del Puente A, Buono P, Mozzillo E, Franzese A. The lumbar bone mineral density is affected by long-term poor metabolic control in adolescents with type 1 diabetes mellitus. Horm Res 2002;58:266-272.Google Scholar
  13. 13.
    Filippi L, Bagnoli F, Margollicci M, Zammarchi E, Tronchin M, Rubaltelli FF. Pathogenic mechanism, prophylaxis, and therapy of symptomatic acidosis induced by acetazolamide. J Investig Med 2002;50:125-132.Google Scholar
  14. 14.
    Bouillon R. Diabetic bone disease. Calcif Tissue Int 1991;49:155-160.Google Scholar
  15. 15.
    Stolk RP, Van Daele PL, Pols HA, Burger H, Hofman A, Birkenhager JC, Lamberts SW, Grobbee DE. Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study. Bone 1996;18:545-549.Google Scholar
  16. 16.
    Nelson DA, Jacober SJ. Why do older women with diabetes have an increased fracture risk? J Clin Endocrinol Metab 2001;86:29-31.Google Scholar
  17. 17.
    Bouillon R. Verhaeghe J, Visser WJ, Suiker AMH. Bone and mineral metabolism in the long term diabetic BB rat. The Endocrine Society, 71st Annual Meeting 1989, Seattle Washington, 1627.Google Scholar
  18. 18.
    Scheiwiller E, Guler HP, Merryweather J, Scandella C, Maerki W, Zapf J, Froesch ER. Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature 1986;323:169-171.Google Scholar
  19. 19.
    Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 2000;23:295-303.Google Scholar
  20. 20.
    Munoz-Torres M, Jodar E, Escobar-Jimenez F, Lopez-Ibarra PJ, Luna JD. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus. Calcif Tissue Int 1996;58:316-319.Google Scholar
  21. 21.
    Jehle PM, Jehle DR, Mohan S, Bohm BO. Serum levels of insulinlike growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. J Endocrinol 1998;159:297-306.Google Scholar
  22. 22.
    Amir G, Rosenmann E, Sherman Y, Greenfeld Z, Ne'eman Z, Cohen AM. Osteoporosis in the Cohen diabetic rat: Correlation between histomorphometric changes in bone and microangiopathy. Lab Invest 2002;82:1399-1405.Google Scholar
  23. 23.
    Vogt MT, Cauley JA, Kuller LH, Nevitt MC. Bone mineral density and blood flow to the lower extremities: The study of Osteoporotic fractures. J Bone Miner Res 1997;12:283-289.Google Scholar
  24. 24.
    Shires R, Avioli LV, Bergfeld MA, Fallon MD, Slatopolsky E, Teitelbaum SL. Effects of semistarvation on skeletal homeostasis. Endocrinology 1980;107:1530-1535.Google Scholar
  25. 25.
    Nyomba BL, Verhaeghe J, Thomasset M, Lissens W, Bouillon R. Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption. Endocrinology 1989;124:565-572.Google Scholar
  26. 26.
    Schneider LE, Schedl HP, McCain T, Haussler MR. Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat. Science 1977;196:1452-1454.Google Scholar
  27. 27.
    Chertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, Deluca HF. Cellular mechanisms of insulin release: The effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 1983;113:1511-1518.Google Scholar
  28. 28.
    Inaba M, Nishizawa Y, Mita K, Kumeda Y, Emoto M, Kawagishi T, Ishimura E, Nakatsuka K, Shioi A, Morii H. Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes. Osteoporos Int 1999;9:525-531.Google Scholar
  29. 29.
    Verrotti A, Basciani F, Carle F, Morgese G, Chiarelli F. Calcium metabolism in adolescents and young adults with type 1 diabetes mellitus without and with persistent microalbuminuria. J Endocrinol Invest 1999;22:198-202.Google Scholar
  30. 30.
    Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 1999;42:51-54.Google Scholar
  31. 31.
    Nyomba BL, Bouillon R, Bidingija M, Kandjingu K, De Moor P. Vitamin D metabolites and their binding protein in adult diabetic patients. Diabetes 1986;35:911-915.Google Scholar
  32. 32.
    Mughal MZ, Eelloo J, Sibartie S, Roberts SA, Maresh M, Sibley, Adams JE. Intrauterine Programming of Urinary Calcium and Magnesium Excretion in Children Born to Mothers with Insulin Dependent Diabetes Mellitus. In: 25th Annual Meeting ASBMR, Sept. 19–23, Minneapolis, Minnesota, 2003:f426.Google Scholar
  33. 33.
    Ahmad T, Ohlsson C, Saaf M, Ostenson CG, Kreicbergs A. Skeletal changes in type-2 diabetic Goto-Kakizaki rats. J Endocrinol 2003;178:111-116.Google Scholar
  34. 34.
    Mathey J, Horcajada-Molteni MN, Chanteranne B, Picherit C, Puel C, Lebecque P, Cubizoles C, Davicco MJ, Coxam V, Barlet JP. Bone mass in obese diabetic Zucker rats: Influence of treadmill running. Calcif Tissue Int 2002;70:305-311.Google Scholar
  35. 35.
    De Schepper J, Smitz J, Rosseneu S, Bollen P, Louis O. Lumbar spine bone mineral density in diabetic children with recent onset. Horm Res 1998;50:193-196.Google Scholar
  36. 36.
    Gunczler P, Lanes R, Paz-Martinez V, Martins R, Esaa S, Colmenares V, Weisinger JR. Decreased lumbar spine bone mass and low bone turnover in children and adolescents with insulin dependent diabetes mellitus followed longitudinally. J Pediatr Endocrinol Metab 1998;11:413-419.Google Scholar
  37. 37.
    Hui SL, Epstein S, Johnston CC Jr. A prospective study of bone mass in patients with type I diabetes. J Clin Endocrinol Metab 1985;60:74-80.Google Scholar
  38. 38.
    Wiske PS, Wentworth SM, Norton JA Jr, Epstein S, Johnston CC Jr. Evaluation of bone mass and growth in young diabetics. Metabolism 1982;31:848-854.Google Scholar
  39. 39.
    Lopez-Ibarra PJ, Pastor MM, Escobar-Jimenez F, Pardo MD, Gonzalez AG, Luna JD, Requena ME, Diosdado MA. Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr Pract 2001;7:346-351.Google Scholar
  40. 40.
    Kemink SA, Hermus AR, Swinkels LM, Lutterman JA, Smals AG. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J Endocrinol Invest 2000;23:295-303.Google Scholar
  41. 41.
    Leidig-Bruckner G, Ziegler R. Diabetes mellitus a risk for osteoporosis? Exp Clin Endocrinol Diabetes 2001;109(Suppl 2):S493-514.Google Scholar
  42. 42.
    Christensen JO, Svendsen OL. Bone mineral in pre-and postmenopausal women with insulin-dependent and non-insulin-dependent diabetes mellitus. Osteoporos Int 1999;10:307-311.Google Scholar
  43. 43.
    el Miedany YM, el Gaafary S, el Baddini MA. Osteoporosis in older adults with non-insulin-dependent diabetes mellitus: Is it sex related? Clin Exp Rheumatol 1999;17:561-567.Google Scholar
  44. 44.
    Weinstock RS, Goland RS, Shane E, Clemens TL, Lindsay R, Bilezikian JP. Bone mineral density in women with type II diabetes mellitus. J Bone Miner Res 1989;4:97-101.Google Scholar
  45. 45.
    Isaia G, Bodrato L, Carlevatto V, Mussetta M, Salamano G, Molinatti GM. Osteoporosis in type II diabetes. Acta Diabetol Lat 1987;24:305-310.Google Scholar
  46. 46.
    Tuominen JT, Impivaara O, Puukka P, Ronnemaa T. Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care 1999;22:1196-1200.Google Scholar
  47. 47.
    Buysschaert M, Cauwe F, Jamart J, Brichant C, De Coster P, Magnan A, Donckier J. Proximal femur density in type 1 and 2 diabetic patients. Diabete Metab 1992;18:32-37.Google Scholar
  48. 48.
    Finger S, Bruckner T, Schneider J, Scheidt-Nave C, Kasperk C, Ziegler R, Leidig-Bruckner G. Prevalence and Predictors of Osteoporosis and Fractures in Type 1 and Type 2 Diabetes Mellitus. In: 25th Annual Meeting ASBMR, Sept. 19–23, Minneapolis, Minnesota, 2003:SU302.Google Scholar
  49. 49.
    Forsen L, Meyer HE, Midthjell K, Edna TH. Diabetes mellitus and the incidence of hip fracture: Results from the Nord-Trondelag Health Survey. Diabetologia 1999;42:920-925.Google Scholar
  50. 50.
    Chiu MY, Sprague SM, Bruce DS, Woodle ES, Thistlethwaite JR Jr, Josephson MA. Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol 1998;9:677-683.Google Scholar
  51. 51.
    Ahmed LA, Joakimsen RM, Berntsen GK, Fonnebo V. Diabetes mellitus and the risk of non-vertebral fractures. In: 25th Annual Meeting ASBMR, Sept. 19–23, Minneapolis, Minnesota, 2003:SU273.Google Scholar
  52. 52.
    Seeley DG, Kelsey J, Jergas M, Nevitt MC. Predictors of ankle and foot fractures in older women. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res 1996;11:1347-1355.Google Scholar
  53. 53.
    Ivers RQ, Cumming RG, Mitchell P, Peduto AJ. Diabetes and risk of fracture: The Blue Mountains Eye Study. Diabetes Care 2001;24:1198-1203.Google Scholar
  54. 54.
    Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cummings SR. Study of Osteoporotic Features Research Group Older women with diabetes have an increased risk of fracture: A prospective study. J Clin Endocrinol Metab 2001;86:32-38.Google Scholar
  55. 55.
    Heath H 3rd, Melton LJ 3rd, Chu CP. Diabetes mellitus and risk of skeletal fracture. N Engl J Med 1980;303:567-570.Google Scholar
  56. 56.
    Nicodemus KK, Folsom AR. Iowa Women's Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001;24:1192-1197.Google Scholar
  57. 57.
    de Liefde II, van der Klift M, de Laet CED, van Daele PLA, Hofman A, Pols HAP. Bone Mineral Density and Fracture Risk in Subjects with Type 2 Diabetes Mellitus: The Rotterdam Study. In: 25th Annual Meeting ASBMR, Sept. 19–23, Minneapolis, Minnesota, 2003:f292.Google Scholar
  58. 58.
    McNair P. Bone mineral metabolism in human type 1 (insulin dependent) diabetes mellitus. Dan Med Bull 1988;35:109-121.Google Scholar
  59. 59.
    Akin O, Gol K, Akturk M, Erkaya S. Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol 2003;17:19-29.Google Scholar
  60. 60.
    Kaukinen K, Salmi J, Lahtela J, Oksa H, Collin P. Response to Iafusco et al.: Effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease (Letter). Diabetes Care 2000;23:713.Google Scholar
  61. 61.
    Lunt H, Florkowski CM, Cook HB, Whitehead MR. Bone mineral density, type 1 diabetes, and celiac disease. Diabetes Care 2001;24:791-792.Google Scholar
  62. 62.
    Horcajada-Molteni MN, Chanteranne B, Lebecque P, Davicco MJ, Coxam V, Young A, Barlet JP. Amylin and bone metabolism in streptozotocin-induced diabetic rats. J Bone Miner Res 2001;16:958-965.Google Scholar
  63. 63.
    Romero DF, Bryer HP, Rucinski B, Isserow JA, Buchinsky FJ, Cvetkovic M, Liu CC, Epstein S. Amylin increases bone volume but cannot ameliorate diabetic osteopenia. Calcif Tissue Int 1995;56:54-61.Google Scholar
  64. 64.
    Gordeladze JO, Reseland JE. A unified model for the action of leptin on bone turnover. J Cell Biochem 2003;88:706-712.Google Scholar
  65. 65.
    Takeda S, Elefteriou F, Karsenty G. Common endocrine control of body weight, reproduction, and bone mass. Annu Rev Nutr 2003;23:403-411.Google Scholar
  66. 66.
    Shibata T, Takeuchi S, Yokota S, Kakimoto K, Yonemori F, Wakitani K. Effects of peroxisome proliferator-activated receptor-alpha and-gamma agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats. Br J Pharmacol 2000;130:495-504.Google Scholar
  67. 67.
    Syversen U, Bakke I, Aune G, Thommesen L. PPAR-Alpha Agonists Increase Bone Mineral Density in Female Rats. In: 25th Annual Meeting ASBMR, Sept. 19–23, Minneapolis, Minnesota, 2003:1161.Google Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Angela M. Inzerillo
    • 1
  • Solomon Epstein
    • 1
  1. 1.Mount Sinai Bone Program, Department of Medicine, Mount Sinai School of Medicine; Division of EndocrinologyBronx VA Medical CenterNew YorkUSA

Personalised recommendations